Sun A. Yoon

St. Vincent's Hospital
Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

FloWise Flow Diverter for Treatment of Unruptured Wide-Neck Intracranial Aneurysms: A Prospective, Multicenter, Single-Arm, Open-Label, Pivotal Study.

FloWise Flow Diverter for Treatment of Unruptured Wide-Neck Intracranial Aneurysms: A Prospective, Multicenter, Single-Arm, Open-Label, Pivotal Study.

Journal: Korean journal of radiology

Published: November 26, 2024

Long-Term Outcome of Rescue Stenting for Acute Intracranial Atherosclerotic Stenosis-Related Large Vessel Occlusion in the Anterior Circulation.

Long-Term Outcome of Rescue Stenting for Acute Intracranial Atherosclerotic Stenosis-Related Large Vessel Occlusion in the Anterior Circulation.

Journal: AJNR. American journal of neuroradiology

Published: July 19, 2024

Understanding the Korean Dialysis Cohort for Mineral, Vascular Calcification, and Fracture (ORCHESTRA) Study: Design, Method, and Baseline Characteristics.

Understanding the Korean Dialysis Cohort for Mineral, Vascular Calcification, and Fracture (ORCHESTRA) Study: Design, Method, and Baseline Characteristics.

Journal: Kidney & blood pressure research

Published: July 09, 2023

Clinical significance of neutrophil-to-lymphocyte ratio on the risk of abdominal aortic calcification and decreased bone mineral density in patients with end-stage kidney disease.

Clinical significance of neutrophil-to-lymphocyte ratio on the risk of abdominal aortic calcification and decreased bone mineral density in patients with end-stage kidney disease.

Journal: PloS one

Published: May 17, 2023

Association between Blood Pressure and Renal Progression in Korean Adults with Normal Renal Function.

Association between Blood Pressure and Renal Progression in Korean Adults with Normal Renal Function.

Journal: Journal of Korean medical science

Published: March 20, 2020

Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78].

Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78].

Journal: Kidney research and clinical practice

Published: April 10, 2018

Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.

Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.

Journal: The Tohoku journal of experimental medicine

Published: August 22, 2017

Sudden bilateral vision loss as the sole manifestation of posterior reversible encephalopathy syndrome from acute uremia: Clinical case report.

Sudden bilateral vision loss as the sole manifestation of posterior reversible encephalopathy syndrome from acute uremia: Clinical case report.

Journal: Medicine

Published: July 07, 2017

Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.

Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.

Journal: Diabetes, obesity & metabolism

Published: March 22, 2017

Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease.

Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease.

Journal: The Korean journal of internal medicine

Published: February 11, 2017

Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).

Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).

Journal: Diabetes, obesity & metabolism

Published: September 22, 2016

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea.

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea.

Journal: Kidney research and clinical practice

Published: September 05, 2016

Showing 1-12 of 26

Last Updated: 09/26/2026